OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
3.120
+0.170 (5.76%)
Jan 21, 2025, 4:00 PM EST - Market closed
OS Therapies Employees
As of December 31, 2022, OS Therapies had 4 total employees, including 3 full-time and 1 part-time employees.
Employees
4
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,854,693
Market Cap
66.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
OSTX News
- 5 days ago - OS Therapies: A Cheap Mid-Stage Biotech Carrying Listeria-Based Immunotherapy - Seeking Alpha
- 6 days ago - Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday? - Benzinga
- 6 days ago - OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma - Business Wire
- 19 days ago - OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 21 days ago - OS Therapies Announces Closing of $6 Million Private Placement - Business Wire
- 26 days ago - OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online - Business Wire
- 4 weeks ago - OS Therapies Announces Pricing of $6 Million Private Placement - Business Wire
- 2 months ago - OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire